Stock AGRX AGILE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Agile Therapeutics, Inc.

Equities

AGRX

US00847L3087

Market Closed - OTC Markets
Other stock markets
 03:52:57 2024-04-15 pm EDT 		5-day change 1st Jan Change
0.3704 USD +1.74% Intraday chart for Agile Therapeutics, Inc. -5.99% -81.01%
Mar. 28 Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Mar. 28 Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Agile Therapeutics: Q4 Earnings Snapshot
AQ
Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M
MT
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
AQ
Agile Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Agile Therapeutics, Inc.(OTCPK:AGRX) dropped from S&P TMI Index
CI
Agile Therapeutics Announces Delisting from Nasdaq
AQ
Agile Therapeutics, Inc.(OTCPK:AGRX) dropped from NASDAQ Composite Index
CI
North American Morning Briefing : Stocks Struggle After New Records
DJ
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
AQ
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
AQ
North American Morning Briefing : Stock Futures -2-
DJ
Maxim Downgrades Agile Therapeutics to Hold From Buy
MT
Agile Therapeutics Inc. Completes Pay-Off the Remainder of its Debt Facility
CI
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
AQ
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
AQ
Top Premarket Gainers
MT
Agile Therapeutics, Inc. Announces Senior Secured Term Loan Credit Facility of Up to $35.0 Million
CI
Agile Therapeutics, Inc. Provides Revenue Guidance for the Full Year Ended December 31, 2023
CI
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGRX Stock
  4. News Agile Therapeutics, Inc.